After a majority stake in its ownership was acquired by MOHS Analytics, Inc. in the last quarter of 2024, Remed Pharmaceuticals recorded accelerated sales in
After a majority stake in its ownership was acquired by MOHS Analytics, Inc. in the last quarter of 2024, Remed Pharmaceuticals recorded accelerated sales in
